WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant drop in short interest in January. As of January 30th, there was short interest totaling 9,096 shares, a drop of 59.3% from the January 15th total of 22,350 shares. Based on an average daily volume of 54,542 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 54,542 shares, the short-interest ratio is currently 0.2 days.

WuXi Biologics (Cayman) Stock Performance

WuXi Biologics (Cayman) stock opened at $10.53 on Thursday. WuXi Biologics has a fifty-two week low of $4.14 and a fifty-two week high of $11.21. The firm’s fifty day moving average price is $9.11 and its 200-day moving average price is $9.01.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.